Halladay Benjamin - Insider Non-Derivative Transactions at Esperion Therapeutics, Inc. (ESPR) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 17, 2025, Halladay Benjamin's relationship to Esperion Therapeutics, Inc. (ESPR) is Officer (Chief Financial Officer), and currently has 467,525 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ESPR insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Halladay Benjamin - Insider Non-Derivative Transactions of ESPR Common Stock

Halladay Benjamin - Insider Non-Derivative Transactions at ESPR

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 18, 2025	Sell -- (Common Stock)	7337	3.67	467525
Sep 18, 2025	Sell -- (Common Stock)	7046	2.81	474862
Jul 18, 2025	Sell -- (Common Stock)	11	1.12	474462
Jun 18, 2025	Sell -- (Common Stock)	7229	1.15	474473
Apr 18, 2025	Sell -- (Common Stock)	8	0.96	481702
Mar 19, 2025	Sell -- (Common Stock)	3535	1.48	481710
Mar 15, 2025	Acquisition -- (Common Stock)	238000	0	485245
Feb 20, 2025	Sell -- (Common Stock)	11	1.86	240671
Jan 18, 2025	Sell -- (Common Stock)	9	2.27	240682
Dec 18, 2024	Sell -- (Common Stock)	3245	2.42	240691
Mar 15, 2024	Acquisition -- (Common Stock)	170000	0	243936
Mar 15, 2023	Acquisition -- (Common Stock)	9200	0	73936